Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences
Open Access
- 25 January 2012
- journal article
- Published by Public Library of Science (PLoS) in PLoS Currents
- Vol. 4, RRN1297
- https://doi.org/10.1371/currents.rrn1297
Abstract
We recently described a modified version of the 6-minute walk test (6MWT) for Duchenne muscular dystrophy (DMD) based partly on the American Thoracic Society (ATS) guidelines. This measure has shown reliability, validity and utility as a primary outcome measure in DMD clinical trials. Because loss of muscle function in DMD occurs against the background of normal childhood growth and development, younger children with DMD can show increase in distance walked during 6MWT over ~1 year despite progressive muscular impairment. In this study, we compare 6-minute walk distance (6MWD) data from DMD boys (n=17) and typically developing control subjects (n=22) to existing normative data from age- and sex-matched children and adolescents. An age- and height-based equation fitted to normative data by Geiger and colleagues was used to convert 6MWD to a percent-predicted (%-predicted) value in boys with DMD. Analysis of %-predicted 6MWD data represents a method to account for normal growth and development, and shows that gains in function at early ages represents stable rather than improving abilities in boys with DMD. Boys with DMD from 4-7 years of age maintain a stable 6MWD approximately 80% of that of typically developing peers, with the deficit progressing at a variable rate thereafter.This publication has 18 references indexed in Scilit:
- Functional changes in Duchenne muscular dystrophyNeurology, 2011
- Reference Values on the 6-Minute Walk Test for Children Living in the United StatesPediatric Physical Therapy, 2011
- North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophyNeuromuscular Disorders, 2010
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial managementThe Lancet Neurology, 2010
- The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophyMuscle & Nerve, 2009
- Six-Minute Walk Test in Children and AdolescentsThe Journal of Pediatrics, 2007
- ATS StatementAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Spirometric Reference Values from a Sample of the General U.S. PopulationAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Reference spirometric values using techniques and equipment that meet ATS recommendations.Published by Elsevier BV ,1981
- The Pathomechanics of Gait in Duchenne Muscular DystrophyDevelopmental Medicine and Child Neurology, 1981